Transaction overview
Matthew J. Zimpfer, general counsel of CNO Financial Group Inc (NYSE:CNO), executed option exercises and sold the resulting common stock in two tranches on February 17 and 18, 2026. In aggregate, Mr. Zimpfer sold 57,370 shares for approximately $2.4 million. The transactions were carried out pursuant to a Rule 10b5-1 trading plan that he adopted on June 9, 2025.
Details of the sales
On February 17, 2026, Mr. Zimpfer sold 23,570 shares of CNO common stock at a weighted average price of $43.1656 per share, producing proceeds of $1,017,274. The prices for shares sold that day ranged from $42.94 to $43.79.
On February 18, 2026, he sold an additional 33,800 shares at a weighted average price of $43.0515 per share, yielding $1,455,279 in proceeds. Those shares traded between $42.92 and $43.28.
Option exercises tied to the sales
Concurrently with the sales, Mr. Zimpfer exercised stock options to acquire the same total of 57,370 shares. On February 17, he exercised options covering 23,570 shares at an exercise price of $23.33 per share. On February 18, he exercised options for 33,800 shares at an exercise price of $17.48 per share. The combined value of the shares acquired through these option exercises was reported as $1,140,712.
Context from recent company results
These insider transactions occurred amid the company’s recent financial disclosures for the fourth quarter of 2025. CNO Financial reported an earnings per share (EPS) figure of $0.95 for the quarter, below the $1.21 that had been anticipated. Revenue for the period was $1.14 billion, which exceeded expectations of $1 billion. The disclosures present a mixed financial picture for the company, with revenue outperforming forecasts while EPS missed estimates.
What is documented
All transaction details above - including dates, share counts, prices, exercise prices, totals, and the existence of a Rule 10b5-1 plan adopted on June 9, 2025 - are taken from the company’s reported filings and disclosures. The revenue and EPS figures for the fourth quarter of 2025 are likewise as reported by the company.
Final note
The combination of option exercises and immediate sales under a prearranged plan is fully documented in the disclosed filings. The company’s recent earnings release shows stronger-than-expected revenue alongside an EPS shortfall, creating a nuanced financial snapshot during the period when these executive transactions took place.